InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Scots-Knight Denise, 董事. Officer active across 2 companies, notably Elanco Animal Health Inc. Cumulatively, 9 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €256k. History available since 30 November 2021. The latest transaction was disclosed on 28 November 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Scots-Knight Denise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
10,314 股0Common StockSEC:0001297000-25-000006:0
18,169 股0Common StockSEC:0001415889-24-028148:0
28,611 股@ US$4.472745.1% 占其流量American Depositary Shares representing Ordinary SharesSEC:0000950170-24-106976:0
188,060 股0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-106417:0
40,712 股@ US$3.693954.9% 占其流量American Depositary Shares representing Ordinary SharesSEC:0000950170-24-078465:0
282,090 股0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-077482:0
20,374 股0Common StockSEC:0001415889-23-015778:0
18,649 股0Common StockSEC:0001415889-22-011975:0
7,307 股0Common StockSEC:0001179110-21-010523:0
9 条申报中的 9 条
About Scots-Knight Denise
Scots-Knight Denise is Administrateur at Elanco Animal Health Inc and Chief Executive Officer at Mereo BioPharma Group plc. The profile contains 9 filings in total, and across the 9 sampled filings between 2021-12-02 and 2025-12-02, sales total 255939 EUR, with the two largest reported for Mereo BioPharma Group plc at 140421.4778029626 EUR on 2024-06-27 and 115517.0947734423 EUR on 2024-09-16.
